OPTUS Pharmaceutical Co., Ltd.

₩5,880As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:131030Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (2.03%)
Div yield —
ROE 8.40%
Pharmaceutical Preparations
Beta (5Y) (0.07)
PE TTM 7.035
TSR TTM (15.76%)
Mkt cap ₩103.8B
ROIC 7.17%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩6,516
10.81%
(58.55%)
Hold 7|6|2|0|3
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
97.95
103.79
114.48
114.05
1.51%
9.46%
22.53%
13.05%
Revenue₩B
6.278
6.509
6.464
6.403
18.82%
19.06%
12.10%
5.99%
Peers (US$76.50M)
Cap (US$)
PE
79.40M
8.079x
68.91M
7.871x
Capital
TTM
5Y
10Y
Leveragex
1.149
(0.434)
(0.357)
EBIT/Intx
1.242
0.130
0.136
Own earn%
34.31
(43.55)
(53.45)
Sh yield%
52.19
27.14
29.33
Owners
Insiders/Inst%
12.05
50.47
Short interest%
2.48
SBC / revenue%
2.63
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
15–21
$1 testx
—
Incr. ROIC%
6